Implementation of the ESC 0 h/1 h high-sensitivity troponin algorithm for decision-making in the emergency department

Rev Esp Cardiol (Engl Ed). 2023 Jun;76(6):468-472. doi: 10.1016/j.rec.2023.01.002. Epub 2023 Jan 18.
[Article in English, Spanish]

Abstract

Diagnosis of non-ST-segment elevation acute coronary syndromes (NSTEACS) is based on 3 cornerstones: clinical presentation, 12-lead electrocardiogram, and cardiac troponin measurement. Advances in the development of high-sensitivity cardiac troponin (hs-cTn) assays have substantially improved the detection of cardiomyocyte injury in a shorter time period, and hs-cTn has consequently been established as the gold-standard biomarker for the assessment of patients with suspected NSTEACS. The implementation of these assays in clinical practice allows a faster "rule-out", especially among low-risk patients, as well as a safer and more rapid "rule-in", with its therapeutic consequences. Current guidelines for the diagnosis of NSTEACS recommend the use of hs-cTn applied in rapid diagnostic algorithms based on serial hs-cTn sampling within the first few hours. The current work provides an overview of the use of hs-cTn for the early detection of NSTEACS.

Keywords: Acute myocardial infarction; Algoritmos rápidos; High-sensitivity cardiac troponin; Infarto agudo de miocardio; Rapid algorithms; Troponina cardiaca de alta sensibilidad.

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Algorithms
  • Biomarkers
  • Emergency Service, Hospital
  • Humans
  • Myocardial Infarction* / diagnosis
  • Troponin
  • Troponin T

Substances

  • Troponin
  • Troponin T
  • Biomarkers